Reproxalap
- Generic Name
- Reproxalap
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H13ClN2O
- CAS Number
- 916056-79-6
- Unique Ingredient Identifier
- F0GIZ22IJH
- Background
Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath